Terkko Navigator / Journal of Ocular Pharmacology and Therapeutics

Eyes on New Product Development

When to Consider Bisphosphonates in Patients on Steroids for Chronic Ocular Inflammatory Conditions

Cross-Linked Hyaluronic Acid as Tear Film Substitute

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials

Ocular Distribution of Cyclosporine Following Topical Administration of OTX-101 in New Zealand White Rabbits

Comparison of the Efficacy of Topical Chloramphenicol 0.5%–Betamethasone 0.2% (CB) and CB Associated with Sodium Hyaluronate/Trehalose/Carbomer Gel Following Strabismus Surgery

Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion

Effect of Topical Corticosteroids on Early Postoperative Intraocular Pressure Following Combined Cataract and Trabecular Microbypass Surgery

Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery

The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells

Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells

Eyes on New Product Development

Fluorophotometric Assessment of Tear Volume and Turnover Rate in Healthy Dogs and Cats

Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use

Antiglaucoma EP2 Agonists: A Long Road That Led Somewhere

Ocular Drug Delivery: Nanotechnology, Physical and Chemical Methods, Vitreous Drug Binding, and Aging Eye

A Human Three-Dimensional In Vitro Model of Lens Epithelial Cells as a Model to Study Mechanisms of Drug-Induced Posterior Subcapsular Cataracts

Outlooks on Three-Dimensional Printing for Ocular Biomaterials Research

Eyes on New Product Development

New Therapies to Reduce Intraocular Pressures

Pain Management in Corneal Collagen Crosslinking for Keratoconus: A Comparative Case Series

Inhibition of LPA1 Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing TGF-β/Smad2/3 Signaling

Eyes on New Product Development

A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method

Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency

A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization

Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%

Analog Derivatization of Cannabidiol for Improved Ocular Permeation

Benzalkonium Chloride Demonstrates Concentration-Dependent Antiviral Activity Against Adenovirus In Vitro

Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery

Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development

Organ-On-A-Chip Technologies for Advanced Blood–Retinal Barrier Models

Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis

Fluoroquinolone Antibiotic Prophylaxis to Prevent Post-Traumatic Bacterial Infectious Endophthalmitis: Using Monte Carlo Simulation to Evaluate the Probability of Success

New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids

RETRACTED: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment

Eyes on New Product Development

Eyes on New Product Development

Simultaneous Intravitreal and Intracameral Injection of Bevacizumab (Avastin) In Neovascular Glaucoma

Expression of Multidrug Resistance Associated Protein 5 (MRP5) on Cornea and Its Role in Drug Efflux

Ocular Gelling Microspheres: In Vitro Precorneal Retention Time and Drug Permeation Through Reconstituted Corneal Epithelium

Topical 0.5% Moxifloxacin Prevents Endophthalmitis in an Intravitreal Injection Rabbit Model

The Etiology of Steroid Cataract

Inhibition of Endotoxin-Induced Uveitis by Methylprednisolone Acetate Nanosuspension in Rabbits

Role of Intravitreal Bevacizumab in Neovascular Glaucoma

Dipeptide Monoester Ganciclovir Prodrugs for Transscleral Drug Delivery: Targeting the Oligopeptide Transporter on Rabbit Retina